Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus

Synapse

Volumn 62, Issue 12, 2008, Pages 944-949

  Brusco, Alicia ^a   Tagliaferro, Patricia ^a   Saez, Trinidad ^a   Onaivi, Emmanuel S ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b WILLIAM PATERSON UNIVERSITY   (United States)

Author keywords

Brain; Electron microscopy; Endocannabinoids; Immunohistochemistry; Marijuana; Neuron

Indexed keywords

CANNABINOID 2 RECEPTOR;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DENDRITE; ENDOTHELIUM CELL; GLIA CELL; GOLGI COMPLEX; HIPPOCAMPUS; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; NERVE ENDING; NONHUMAN; PERIKARYON; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; ROUGH ENDOPLASMIC RETICULUM; SOMATIC CELL; TISSUE SECTION;

AMINO ACID SEQUENCE; ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MALE; MICROSCOPY, IMMUNOELECTRON; MOLECULAR SEQUENCE DATA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; SYNAPTIC MEMBRANES;

EID: 56549089453     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20569     Document Type: Article

References (28)

1. Ashton JC, Friberg D, Darlington CL, Smith PF. 2006. Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study. Neurosci Lett 396:113-116.
2. Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, Fredduzzi S, Reggiani A. 2006. CB2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms. Eur J Neurosci 23:1530-1538.
3. Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R. 1998. An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 353:23-31.
4. Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J. 2003. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23:11136-11141.
5. Benito C, Kim WK, Chavarria I, Hillard CJ, Mackie K, Tolon RM, Williams K, Romero J. 2005. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci 25:2530-2536.
6. Carlisle SJ, Marciano-Cabral F, Staab A, Ludwick C, Cabral GA. 2002. Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol 2:69-82.
7. Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P. 1995. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett 369:177-182.
8. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. 1995. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376-3380.
9. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P. 1995. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
10. Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M. 2004. Human brain endothelium: Coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res 132:87-92.
11. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR. 2006. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res 1071:10-23.
12. Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME. 1999. Evaluation of the cannabinoid CB2 receptor-selective antagonist. SR144528: Further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol 377:117-125.
13. Jhaveri MD, Elmes SJR, Richardson D, Barrett DA, Kendall DA, Mason R, Chapman V. 2008. Evidence for a novel functional role of cannabnoid CB2 receptors in the thalamus of neuropathic rats. Eur J Neurosci 27:1722-1730.
14. Lu Q, Straiker A, Lu Q, Maguire G. 2000. Expression of CB2 cannabinoid receptor mRNA in adult rat retina. Vis Neurosci 17:91-95.
15. Matyas F, Yanovsky Y, Mackie K, Kelsch W, Misgeld U, Freund TF. 2006. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137:337-361.
16. Nunez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonzalez S, Tolon RM, Romero J. 2004. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study. Synapse 53:208-213.
17. Onaivi ES, Ali SF, Chirwa SS, Zwiller J, Thiriet N, Akinshola BE, Ishiguro H. 2002a. Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation. Ann N Y Acad Sci 965:28-46.
18. Onaivi ES, Leonard CM, Ishiguro H, Zhang PW, Lin Z, Akinshola BE, Uhl GR. 2002b. Endocannabinoids and cannabinoid receptor genetics. Prog Neurobiol 66:307-344.
19. Onaivi ES, Ishiguro H, Sejal P, Meozzi PA, Myers L, Tagliaferro P, Hope B, Leonard CM, Uhl GR, Brusco A, Gardner E. 2006. Methods to study the behavioral effects and expression of CB2 cannabinoid receptor and its gene transcripts in the chronic mild stress model of depression. Methods Mol Med 123:291-298.
20. Ong WY, Mackie K. 1999. A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. J Neurocytol 28:39-45.
21. Paxinos G, Watson C. 2005. The rat brain in stereotaxic coordinates. Amsterdam: Elsevier Academic Press. xliii, [166] p.
22. Pazos MR, Nunez E, Benito C, Tolon RM, Romero J. 2004. Role of the endocannabinoid system in Alzheimer's disease: New perspectives. Life Sci 75:1907-1915.
23. Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208-212.
24. Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H. 2003. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170:4953-4962.
25. Sheng WS, Hu S, Min X, Cabral GA, Lokensgard JR, Peterson PK. 2005. Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes. Glia 49:211-219.
26. Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A. 1996. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 93:3984-3989.
27. Sugiura T, Waku K. 2000. 2-Arachidonoylglycerol and the cannabinoid receptors. Chem Phys Lipids 108:89-106.
28. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA. 2005. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329-332.